Barclays PLC Publication of Pricing Supplement (7827H)
March 26 2020 - 1:45PM
UK Regulatory
TIDMBARC
RNS Number : 7827H
Barclays PLC
26 March 2020
Publication of Pricing Supplement
The following pricing supplement (the "Pricing Supplement") is
available for viewing:
Pricing Supplement in relation to Barclays PLC's issue of USD
300,000,000 Zero Coupon Callable Notes due 2050 under the Barclays
PLC GBP60,000,000,000 Debt Issuance Programme.
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting to access this service, as your right
to do so is conditional upon complying with the requirements set
out below.
To view the full document, please paste the following URL into
the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/7827H_1-2020-3-26.pdf
A copy of the Pricing Supplement has been submitted to the
National Storage Mechanism and will shortly be available for
inspection at: www.morningstar.co.uk/uk/NSM
For further information, please contact:
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT : You must read the following before continuing: The
following applies to the Pricing Supplement available by clicking
on the link above, and you are therefore advised to read this
carefully before reading, accessing or making any other use of the
Pricing Supplement. In accessing the Pricing Supplement, you agree
to be bound by the following terms and conditions, including any
modifications to them, any time you receive any information from us
as a result of such access.
The Pricing Supplement referred to above must be read in
conjunction with the base prospectus dated 25 February 2020 (the
"Prospectus").
THE PRICING SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED OTHER
THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER
WHATSOEVER. THE PRICING SUPPLEMENT MAY ONLY BE DISTRIBUTED OUTSIDE
THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED
IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT
OF 1933, AS AMENDED (THE "SECURITIES ACT"). ANY FORWARDING,
DISTRIBUTION OR REPRODUCTION OF THE PRICING SUPPLEMENT IN WHOLE OR
IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY
RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS
OF OTHER JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION. ANY NOTES ISSUED OR TO BE
ISSUED PURSUANT TO THE PRICING SUPPLEMENT AND THE PROSPECTUS HAVE
NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR
THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER
JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE
PRICING SUPPLEMENT AND THE PROSPECTUS MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN AN OFFSHORE TRANSACTION
TO A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE WITH RULE 903
OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT.
Please note that the information contained in the Pricing
Supplement and the Prospectus referred to above may be addressed to
and/or targeted at persons who are residents of particular
countries (specified in the Pricing Supplement and/or the
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Pricing Supplement and/or the Prospectus
is not addressed. Prior to relying on the information contained in
the Pricing Supplement and/or the Prospectus you must ascertain
from the Pricing Supplement and the Prospectus whether or not you
are part of the intended addressees of the information contained
therein.
Confirmation of your Representation : In order to be eligible to
view the Pricing Supplement or make an investment decision with
respect to any Notes issued or to be issued pursuant to the Pricing
Supplement, you must be a person other than a U.S. person (within
the meaning of Regulation S under the Securities Act). By accessing
the Pricing Supplement, you shall be deemed to have represented
that you are not a U.S. person, and that you consent to delivery of
the Pricing Supplement via electronic publication.
You are reminded that the Pricing Supplement has been made
available to you on the basis that you are a person into whose
possession the Pricing Supplement may be lawfully delivered in
accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Pricing Supplement to any other person.
The Pricing Supplement does not constitute, and may not be used
in connection with, an offer or solicitation in any place where
offers or solicitations are not permitted by law. If a jurisdiction
requires that the offering be made by a licensed broker or dealer
and the underwriters or any affiliate of the underwriters is a
licensed broker or dealer in that jurisdiction, the offering shall
be deemed to be made by the underwriters or such affiliate on
behalf of the issuer in such jurisdiction. Under no circumstances
shall the Pricing Supplement constitute an offer to sell, or the
solicitation of an offer to buy, nor shall there be any sale of any
Notes issued or to be issued pursuant to the Pricing Supplement, in
any jurisdiction in which such offer, solicitation or sale would be
unlawful.
The Pricing Supplement has been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the issuer, its
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Pricing Supplement made available to you
in electronic format and the hard copy version available to you on
request from the issuer.
Your right to access this service is conditional upon complying
with the above requirement.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCDQLFLBXLLBBF
(END) Dow Jones Newswires
March 26, 2020 13:45 ET (17:45 GMT)
Barclays (LSE:BARC)
Historical Stock Chart
From Apr 2024 to May 2024
Barclays (LSE:BARC)
Historical Stock Chart
From May 2023 to May 2024